Sponsor Pipeline

Chinese SLE Treatment And Research Group Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
12
Active Trials
6
Recruiting
2
Phase 3
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT05916781
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in…
overall status: Recruiting → Unknown
Active Trials by Phase
Phase 4
7
Phase 3
1
Phase 2/3
1
Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05962840 Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of… ANCA Associated Vasculitis Recruiting
NCT05965284 Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of… ANCA-associated Vasculitis Recruiting
NCT07008196 Telitacicept for the Treatment of Refractory RA Rheumatoid Arthritis (RA) Not Yet Recruiting
NCT07013838 The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis Takayasu Arteritis (TAK) Not Yet Recruiting
NCT07451665 Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active… Takayasu Arteritis (TAK) Not Yet Recruiting
NCT07643038 Treatment Strategy for Patients With RA-ILD Rheumatoid Arthritis Associated Interstitial Lung Disease Not Yet Recruiting
NCT07381465 Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus Lupus Erythematosus, Systemic Active, Not Recruiting
Phase 3
NCT04582136 Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus Systemic Lupus Erythematosus Active, Not Recruiting
Phase 2/3
NCT07657793 Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia Systemic Lupus Erythematosus Recruiting
Phase 1
NCT06881290 Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus Lupus Erythematosus, Systemic Recruiting
Not specified
NCT06167174 Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics… Lupus Nephritis Recruiting
NCT06887517 Chinese Rheumatism Biobank(CRB) Lupus Erythematosus, Systemic Recruiting
Disease Areas
Get alerts when Chinese SLE Treatment And Research Group's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free